Latest statistics and disclosures from Harbourvest Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SWI, AXLA, EVLO, KLDO, WORK, and represent 82.82% of Harbourvest Partners's stock portfolio.
- Added to shares of these 6 stocks: AXLA (+$8.7M), EVLO (+$6.4M), KLDO, TENB, ISEE, EPZM.
- Started 3 new stock positions in ISEE, TENB, EPZM.
- Reduced shares in these 10 stocks: WORK (-$14M), PINS (-$7.0M), FSLY, , ALRM, PD, KALA, CRWD, REAL, RYTM.
- Sold out of its positions in ALRM, CRWD, FSLY, KALA, MGI, PD, RYTM, REAL, PRTS, UPWK. Xpresspa Group.
- Harbourvest Partners was a net seller of stock by $-11M.
- Harbourvest Partners has $232M in assets under management (AUM), growing by 11.99%.
Portfolio Holdings for Harbourvest Partners
Companies in the Harbourvest Partners portfolio as of the June 2020 quarterly 13F filing
|Company (Ticker)||Portfolio Weight||Valued At||Change in Shares||Share Count||Share Price|
|Solarwinds Corp. Common (SWI)||60.0||$139M||7.9M||17.67|
|Axcella Health Common (AXLA)||6.7||$16M||+128%||2.8M||5.53|
|Evelo Biosciences Common (EVLO)||6.5||$15M||+73%||3.1M||4.90|
|Kaliedo Biosciences Common (KLDO)||5.9||$14M||+57%||1.8M||7.43|
|Slack Technologies Common CL A (WORK)||3.8||$8.9M||-60%||285k||31.09|
|Finjan Holdings Common (FNJN)||2.9||$6.6M||4.3M||1.54|
|Rubius Therapeutics Common (RUBY)||2.5||$5.9M||987k||5.98|
|Pinterest Common CL A (PINS)||2.0||$4.7M||-60%||211k||22.17|
|Sonos Common (SONO)||1.9||$4.4M||303k||14.63|
|Zuora Common (ZUO)||1.0||$2.4M||187k||12.75|
|LendingClub Corp. Common (LC)||1.0||$2.3M||513k||4.55|
|Yext Common (YEXT)||0.8||$1.9M||115k||16.61|
|Stitchfix Common CL A (SFIX)||0.7||$1.7M||67k||24.94|
|Spark Networks SE Sponsored ADR (LOV)||0.7||$1.7M||503k||3.30|
|Tenable Holdings Common (TENB)||0.7||$1.7M||NEW||55k||29.81|
|IVERIC Bio Common (ISEE)||0.7||$1.6M||NEW||309k||5.10|
|PluralSight Common CL A (PS)||0.4||$958k||53k||18.06|
|Lyft Common CL A (LYFT)||0.4||$851k||26k||33.00|
|Cytomx Therapeutics Common (CTMX)||0.3||$660k||79k||8.33|
|Proteostasis Therapeutics Common (PTI)||0.3||$604k||441k||1.37|
|Epizyme Common (EPZM)||0.2||$396k||NEW||25k||16.04|
|Trevena Common (TRVN)||0.2||$351k||234k||1.50|
|Antero Resources Common (AR)||0.1||$335k||132k||2.54|
|Exagen Common (XGN)||0.1||$322k||26k||12.39|
|Castlight Health Common CLB (CSLT)||0.1||$290k||349k||0.83|
|NextCure Common (NXTC)||0.1||$215k||10.0k||21.41|
|Ramaco Resources Common (METC)||0.0||$32k||15k||2.14|
|Hallador Energy Resources Common (HNRG)||0.0||$9.0k||14k||0.63|
Past Filings by Harbourvest Partners
SEC 13F filings are viewable for Harbourvest Partners going back to 2010
- Harbourvest Partners 2020 Q1 filed May 14, 2020
- Harbourvest Partners 2019 Q4 filed Feb. 13, 2020
- Harbourvest Partners 2019 Q3 filed Nov. 13, 2019
- Harbourvest Partners 2019 Q2 amended filed Sept. 5, 2019
- Harbourvest Partners 2019 Q2 filed Aug. 13, 2019
- Harbourvest Partners 2019 Q1 filed May 13, 2019
- Harbourvest Partners 2018 Q4 filed Feb. 14, 2019
- Harbourvest Partners 2018 Q3 filed Nov. 14, 2018
- Harbourvest Partners 2018 Q2 filed Aug. 14, 2018
- Harbourvest Partners 2018 Q1 filed May 15, 2018
- Harbourvest Partners 2017 Q4 filed Feb. 14, 2018
- Harbourvest Partners 2017 Q3 filed Nov. 14, 2017
- Harbourvest Partners 2017 Q2 filed Aug. 14, 2017
- Harbourvest Partners 2017 Q1 filed May 15, 2017
- Harbourvest Partners 2016 Q4 amended filed May 9, 2017
- Harbourvest Partners 2016 Q4 filed Feb. 14, 2017